Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Goat hair growth and follicle activity change with the seasons and differ between males and females.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

The document's conclusion cannot be provided because the document is not accessible or understandable.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Eating a lot of soy might lower the chance of early hair loss in men likely to get it.

Early treatment of acne is crucial to prevent scarring and psychological effects.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.